Trials / Completed
CompletedNCT01695200
Omega-3 Fatty Acids in Autism Spectrum Disorders
The Role of Omega-3 Fatty Acids in the Management of Singaporean Children With Autism Spectrum Disorders
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- National Healthcare Group, Singapore · Other Government
- Sex
- All
- Age
- 5 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a 12-week open label trial to evaluate whether omega-3 fatty acids is effective in reducing the severity of autism and its comorbidities.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Omega-3 fatty acids |
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2013-01-01
- Completion
- 2013-01-01
- First posted
- 2012-09-27
- Last updated
- 2013-05-01
Locations
1 site across 1 country: Singapore
Source: ClinicalTrials.gov record NCT01695200. Inclusion in this directory is not an endorsement.